Valuation
Is the price right?2/2 inputs reported · High confidence
Weaker than most peers on:
- ▼ P/B
- ▼ Earnings yield
Behind the score
Earnings yield (P/E) and book yield (P/B) versus other banks and insurers.
Bringing the fundamentals into focus…
Price as of close on Nov 3, 2026 · Financials updated Nov 2, 2026
2/2 inputs reported · High confidence
Weaker than most peers on:
Earnings yield (P/E) and book yield (P/B) versus other banks and insurers.
1/1 inputs reported · High confidence
Close to the peer norm on every measure.
Earnings-per-share growth versus other banks and insurers.
2/2 inputs reported · High confidence
Stronger than most peers on:
Return on equity and return on assets versus other banks and insurers.
Not rated for banks and insurers: debt and share-price swings say little about their risk. We leave it blank rather than fill the gap with a made-up middle value.
Valuation, growth and profitability scores: higher is better. Risk: 0 is lower, 2 is higher. Risk is a relative proxy, not a bankruptcy probability. Scores depend on available sector peers.
Got weaker
| Previous year | Latest year | Change | |
|---|---|---|---|
| Net income (12 months) | 853.0B CLP | 1.02T CLP | +19.8% |
| Free cash flow (12 months) | 419.2B CLP | −29.3B CLP | turned negative |
| Debt | 4.34T CLP | 3.43T CLP | −20.8% |
| Cash | 2.77T CLP | 2.09T CLP | −24.5% |
From the company’s own SEC filings, as filed. Twelve-month figures roll forward one year at a time.
| Key ratios | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | Change |
|---|---|---|---|---|---|---|
| Return on assets (ROA) | -1.3% | 1.2% | 0.8% | 1.2% | 1.5% | ▲ 0.3 pts |
| Return on equity (ROE) | -19.4% | 16.3% | 11.1% | 16.2% | 18.2% | ▲ 2.0 pts |
| Debt to equity | 3.71× | 1.83× | 1.99× | 0.83× | 0.61× | ▼ 26% |
| Interest coverage | 0.97× | — | — | — | — | — |
Price history is added with the daily price update and will appear after the next one.